Addex Therapeutics (ADXN) Market Capitalization (2020 - 2026)

Addex Therapeutics has disclosed Market Capitalization across 7 years of filings, most recently posting $5.6 million for Q1 2026.

• In Q1 2026, Market Capitalization fell 6.22% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (down 6.22% YoY), while the FY2025 annual figure was $6.9 million, up 20.69% from the prior year.
• Market Capitalization came in at $5.6 million for Q1 2026 at Addex Therapeutics, down from $6.9 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $641.7 million in Q1 2022 to a low of $3.7 million in Q4 2023.
• Average Market Capitalization over 5 years is $77.9 million, with a median of $7.7 million recorded in 2025.
• Year-over-year, Market Capitalization plunged 96.05% in 2023 and surged 52.77% in 2024.
• Over 5 years, Market Capitalization stood at $94.9 million in 2022, then tumbled by 96.05% to $3.7 million in 2023, then surged by 52.77% to $5.7 million in 2024, then advanced by 20.69% to $6.9 million in 2025, then fell by 18.52% to $5.6 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $5.6 million in Q1 2026, $6.9 million in Q4 2025, and $7.7 million in Q3 2025.